B.

b.value AG

VC
Portfolio

6+ companies

Team

5 partners

Investor activity
Investments in last 12 months: 0

Meet the Team

DC

Dr. Cornelia Bähr

Senior Investment Manager

DM

Dr. Marie Kappen

Senior Investment Manager

DI

Dr. Isabelle Schiffer

Investment Manager

DP

Dipl.-Kfm. Peter Kallien

Managing Director

DG

Dr. Georg Lentzen

Managing Director

Portfolio Companies (6)

Other

FI

FibreCoat

Advanced Materials·Series A (2021), Series B (2024)

"Discovered via perplexity (medium confidence)"

Develops lightweight, conductive fiber coatings for automotive, defense, and space applications by coating metals/plastics onto fibers during spinning.

PL

PL BioScience

Biotechnology·Series A (€7.8M, 2024)

"Discovered via perplexity (medium confidence)"

Produces Human Platelet Lysate (HPL) as animal-free cell culture media for regenerative medicine and cell therapy.

FL

FluIDect

Biotechnology/Industrial Tech·Seed (multi-million, 2023)

"Discovered via perplexity (medium confidence)"

Builds SpheroScan sensors for real-time microbial contamination detection in food, biotech, and water processes.

CE

Cellbricks Therapeutics

Biotechnology·Early-stage

"Discovered via perplexity (medium confidence)"

Develops cell-based therapeutics (e.g., for tissue repair); expanded to Boston for clinical programs.

SE

SenseUP Biotechnology

Biotechnology (AgriTech)·Seed (€2.4M+ extension to €3.5M, 2025-2026)

"Discovered via perplexity (medium confidence)"

Creates dsRNA biopesticides using bacterial delivery for precise, stable crop protection.

TR

traceless materials

Advanced Materials·Series A (€36.6M+, 2023)

"Discovered via perplexity (medium confidence)"

Produces biocircular, compostable granulate from plant residues as plastic alternative for packaging.

Frequently Asked Questions

See if b.value AG is a match for your startup

Upload your pitch deck to see how well you match with b.value AG and 200+ other VC firms.